SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
PCRX
--
0.00%
--
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020
PARSIPPANY, N.J., July 30, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets on Thursday, August 6, 2020. Following the release, the comp
GlobeNewswire · 4d ago
Pacira BioSciences Announces Settlement of Government Investigation
Pacira to Pay $3.5 Million to Settle Various Claims with No Admission of WrongdoingPARSIPPANY, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today announced
GlobeNewswire · 5d ago
The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13)
Benzinga · 07/14 12:04
Did Hedge Funds Make The Right Call On Pacira Biosciences Inc (PCRX)?
Insider Monkey · 07/12 00:02
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 07/10 11:25
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)
Benzinga · 07/09 12:09
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)
Benzinga · 07/08 11:31
Pacira Bio prices upsized convertible debt offering
Seeking Alpha - Article · 07/08 09:00
Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025
GlobeNewswire · 07/08 00:51
Pacira BioSciences under pressure on preliminary Q2 results
Seeking Alpha - Article · 07/06 21:29
Pacira BioSciences, Inc. Announces Proposed Offering of $300.0 Million Aggregate Principal Amount of Convertible Senior Notes
GlobeNewswire · 07/06 21:02
Pacira BioSciences Reports Preliminary Total Revenue of $75.5 Million for Second Quarter of 2020
GlobeNewswire · 07/06 21:01
Pacira BioSciences Reports Q2 Preliminary Sales $75.5M
Benzinga · 07/06 20:02
Needham Maintains Buy on Pacira BioSciences, Raises Price Target to $64
Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and raises the price target from $52 to $64.
Benzinga · 07/06 09:44
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)
Benzinga · 07/02 12:21
Pacira BioSciences Reports Co. Notified DePuy Synthes Sales Deal To Market, Promote EXPAREL Will Terminate On Jan. 2, 2021
Benzinga · 07/02 11:35
Pacira BioSciences Announces Conclusion of EXPAREL Agreement with DePuy Synthes
Pacira BioSciences, Inc. (PCRX), a leading provider of innovative non-opioid pain management options, today announced that the company has notified DePuy Synthes Sales Inc. that the agreement between the two companies to jointly market and promote the use of E
GlobeNewswire · 07/02 11:30
The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29)
Benzinga · 06/30 11:41
U.S. FDA seeks more data on Heron Therapeutics' non-opioid painkiller
Reuters · 06/29 14:00
Pacira BioSciences surges after Heron receives CRL
Seeking Alpha - Article · 06/29 13:56